 |

2001 Press Releases in PDF Format
January 9
SANGAMO
BIOSCIENCES CEO PROVIDES CORPORATE UPDATE AT JP MORGAN H&Q HEALTHCARE
CONFERENCE
January
9
SANGAMO BIOSCIENCES AND RENESSEN APPLYING GENE REGULATION TECHNOLOGY TO
CREATE IMPROVED CROPS
January
16
SANGAMO BIOSCIENCES REPORTS ON-LINE PUBLICATION OF GENE REGULATION DATA
IN THE JOURNAL OF BIOLOGICAL CHEMISTRY
January
25
SANGAMO BIOSCIENCES TO RELEASE FOURTH-QUARTER AND YEAR-END 2000 FINANCIAL
RESULTS ON FEBRUARY 1, 2001
February
1
SANGAMO BIOSCIENCES REPORTS FOURTH-QUARTER
AND YEAR-END FINANCIAL RESULTS
March
6
SANGAMO BIOSCIENCES LICENSES CELL-BASED SELECTION SYSTEM FROM MASSACHUSETTS
INSTITUTE OF TECHNOLOGY AND HARVARD UNIVERSITY
March
14
SANGAMO BIOSCIENCES GRANTED U.K. PATENT COVERING REGULATION OF GENE EXPRESSION
USING ENGINEERED ZINC FINGER DNA-BINDING PROTEINS
April
5
SANGAMO BIOSCIENCES AND ONYX PHARMACEUTICALS ANNOUNCE STRATEGIC ALLIANCE
TO DEVELOP NOVEL CANCER THERAPEUTICS
April
18
SANGAMO BIOSCIENCES TO RELEASE FIRST-QUARTER 2001 FINANCIAL RESULTS ON
APRIL 25, 2001
April
25SANGAMO
BIOSCIENCES REPORTS FIRST-QUARTER FINANCIAL RESULTS
May
7
SANGAMO BIOSCIENCES ANNOUNCES REGULATION OF OVER 300 HUMAN GENES
May
29
SANGAMO BIOSCIENCES REPORTS DEATH OF ALAN P. WOLFFE, PH.D.
May
30
SANGAMO BIOSCIENCES ANNOUNCES OPTION TO ACQUIRE GENDAQ LTD.
May
31
SANGAMO BIOSCIENCES ANNOUNCES PRESENTATION OF FIRST PRECLINICAL DATA USING
ZFP TRANSCRIPTION FACTORS
First Evidence of Physiologic Response with Potential New Therapeutic
Paradigm
June
6
SANGAMO BIOSCIENCES AND THE R.W. JOHNSON &JOHNSON PHARMACEUTICAL RESEARCH
INSTITUTE ESTABLISH COLLABORATIVE RESEARCH PROGRAM
Partnership to Explore Application of Novel Technology to Small Molecule
Screening
June
11
SANGAMO BIOSCIENCES AND MEDAREX ANNOUNCE COLLABORATION TO DISCOVER AND
DEVELOP THERAPEUTIC ANTIBODIES TO G-PROTEIN COUPLED RECEPTORS
June
26
SANGAMO BIOSCIENCES AND ZYCOS ANNOUNCE COLLABORATION TO ASSESS GENE TRANSFER
TECHNOLOGY
June
28
SANGAMO BIOSCIENCES SIGNS DEFINITIVE AGREEMENT TO ACQUIRE GENDAQ LTD.
Sangamo Consolidates Leadership in the Emerging Field of Gene Regulation
July
5
SANGAMO BIOSCIENCES, INC. COMPLETES GENDAQ LTD. ACQUISITION.
July
11
CHARLES RIVER AND SANGAMO BIOSCIENCES TO COLLABORATE IN THE DEVELOPMENT
OF TRANSGENIC RAT MODELS
July
12
SANGAMO BIOSCIENCES ANNOUNCES SECOND-QUARTER 2001 TELECONFERENCE
July
17
SANGAMO BIOSCIENCES ANNOUNCES SMALL MOLECULE SCREENING COLLABORATION WITH
PHARMACIA
July
19
SANGAMO BIOSCIENCES REPORTS SECOND-QUARTER FINANCIAL RESULTS
August
7
SANGAMO BIOSCIENCES REPORTS PUBLICATION OF DATA IN NATURE BIOTECHNOLOGY
AND METHODS IN ENZYMOLOGY
Enhanced Methods Developed to Engineer DNA-binding Proteins
September
4
SANGAMO BIOSCIENCES, INC. ANNOUNCES THE APPOINTMENT OF CARL O. PABO, PH.D.
AS SENIOR VICE PRESIDENT AND CHIEF SCIENTIFIC OFFICER
October
11
SANGAMO BIOSCIENCES ANNOUNCES THIRD-QUARTER 2001 TELECONFERENCE
October
18
SANGAMO BIOSCIENCES REPORTS THIRD-QUARTER FINANCIAL RESULTS
October
18
SANGAMO BIOSCIENCES ANNOUNCES FIRST MAJOR THERAPEUTICS MILESTONE. ACHIEVEMENT
TRIGGERS $1.4 MILLION PAYMENT TO SANGAMO
October
29
SANGAMO BIOSCIENCES GRANTED U.K. PATENT COVERING METHODS OF ENGINEERING
ZINC FINGER DNA-BINDING PROTEINS
|
 |
 |